Market Assessment, Dup15q Syndrome Executive Insights Dup15q Syndrome Executive Insights US/EU5/China Report

Dup15q Syndrome - Executive Insights - Dup15q Syndrome | Executive Insights | US/EU5/China
- Dup15q Syndrome | Executive Insights | US/EU5/China

Anamika Ghosh, Ph.D.

Anamika Ghosh, M.Sc., Ph.D., is a manager on the Oncology team at Clarivate. She has expertise in various solid and hematological malignancies and immune-oncology drug classes, such as immune checkpoint inhibitors and CAR T-cell therapies. As a Ph.D. and postdoctoral fellow at the International Centre for Genetic Engineering and Biotechnology (ICGEB), Dr. Ghosh studied host-pathogen interactions during Mycobacterium tuberculosis and Dengue virus infections. She received her Ph.D. in life sciences from ICGEB and an M.Sc. in biomedical sciences from the University of Delhi.

Buy report Login to access report

Back to all Market Assessment reports

Contact us

Investors

Careers

Login

Dup15q Syndrome – Executive Insights – Dup15q Syndrome | Executive Insights | US/EU5/China

Table of contents

Related Market Assessment Reports

Myasthenia Gravis – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)

Urticaria – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis – Chronic Inducible Urticaria (US) 2023

Ulcerative Colitis – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis – Adult (US)

Asthma | Unmet Need | Severe Asthma | US/EU | 2021

Asthma – Unmet Need – Detailed, Expanded Analysis – Severe Asthma (US/EU)